SABINI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.547
EU - Europa 780
AS - Asia 687
SA - Sud America 84
AF - Africa 42
OC - Oceania 3
Totale 3.143
Nazione #
US - Stati Uniti d'America 1.511
SG - Singapore 279
SE - Svezia 258
CN - Cina 170
DE - Germania 149
IT - Italia 126
HK - Hong Kong 118
BR - Brasile 70
BG - Bulgaria 57
GB - Regno Unito 50
FR - Francia 36
CA - Canada 28
VN - Vietnam 28
IN - India 27
RU - Federazione Russa 27
AT - Austria 21
TR - Turchia 19
CI - Costa d'Avorio 18
FI - Finlandia 17
SN - Senegal 17
JP - Giappone 13
UA - Ucraina 10
NL - Olanda 7
BD - Bangladesh 6
PL - Polonia 6
BE - Belgio 5
VE - Venezuela 5
IQ - Iraq 4
PH - Filippine 4
AR - Argentina 3
AU - Australia 3
ES - Italia 3
IE - Irlanda 3
MA - Marocco 3
MX - Messico 3
SA - Arabia Saudita 3
AL - Albania 2
AZ - Azerbaigian 2
CO - Colombia 2
ID - Indonesia 2
KZ - Kazakistan 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MZ - Mozambico 1
PY - Paraguay 1
Totale 3.143
Città #
Ashburn 190
Woodbridge 152
Dallas 143
Fairfield 135
Hong Kong 115
Singapore 112
Houston 100
Chandler 93
Santa Clara 87
Seattle 69
Sofia 57
Wilmington 49
Ann Arbor 47
New York 39
Cambridge 37
Los Angeles 35
Shanghai 35
Beijing 34
Munich 32
Serra 28
Boardman 27
Frankfurt am Main 24
Florence 21
Vienna 21
London 20
Ottawa 19
Princeton 19
Abidjan 18
Bremen 17
Dakar 17
Lawrence 17
Medford 16
Pisa 12
Des Moines 11
Dearborn 10
Tokyo 10
Dong Ket 9
Istanbul 8
Marseille 8
Atlanta 7
Buffalo 7
Düsseldorf 7
Helsinki 7
Rome 7
Turku 7
Chennai 6
Guangzhou 6
Ogden 6
Warsaw 6
Brussels 5
Denver 5
Izmir 5
Manchester 5
Redondo Beach 5
San Diego 5
Tianjin 5
Boulder 4
Changsha 4
Chicago 4
Ho Chi Minh City 4
Lancaster 4
Milan 4
Nanchang 4
Nanjing 4
Orem 4
Ossé 4
Poplar 4
Stockholm 4
Toronto 4
Aosta 3
Baghdad 3
Brooklyn 3
Caracas 3
Columbus 3
Da Nang 3
Dublin 3
Fuzhou 3
Hebei 3
Jiaxing 3
Lucca 3
Montreal 3
Ningbo 3
Palermo 3
Pesqueira 3
Taiyuan 3
The Dalles 3
Xi'an 3
Amsterdam 2
Araxá 2
Baku 2
Belo Horizonte 2
Calgary 2
Chengdu 2
Cosmópolis 2
Genoa 2
Goiânia 2
Hanoi 2
Indore 2
Johannesburg 2
Kathmandu 2
Totale 2.126
Nome #
Natural history of graves’ orbitopathy after treatment 253
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 235
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 224
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 199
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 189
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 172
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 172
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 165
Occurrence of Graves’ Orbitopathy and of Graves’ hyperthyroidism after a trauma to the eye 165
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 161
A case of drug-induced Graves’ Orbitopathy after combination therapy with Tremelimumab and Durvalumab 157
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 153
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 150
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 132
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 118
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy 110
Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimus 105
null 93
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 87
null 80
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study 74
Totale 3.194
Categoria #
all - tutte 9.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 4 4 9 8 11 6 17
2021/2022327 0 3 2 44 87 31 3 9 40 35 4 69
2022/2023417 58 73 39 27 30 38 1 41 80 0 27 3
2023/2024139 8 5 19 2 18 28 10 9 0 3 23 14
2024/2025741 5 19 9 35 82 69 26 16 80 102 80 218
2025/2026632 97 116 141 92 123 63 0 0 0 0 0 0
Totale 3.194